Heart Failure Study at Lund University to Use Arrays, NGS, Mass Spec | GenomeWeb

NEW YORK (GenomeWeb) – The European Commission has awarded researchers at Lund University in Sweden €1.5 million ($1.7 million) to probe the mechanics of heart failure using proteomic, genomic, and epidemiological approaches.

The project, called "Integrative omics of heart failure to inform discovery of novel drug targets and clinical biomarkers," or inHForm, recently commenced and is slated to run through March 2021. The EC's Horizon 2020 research and innovation program is funding the effort and Lund is inHForm's sole participant.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.